OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Antiviral Drug Tilorone Is a Potent and Selective Inhibitor of Acetylcholinesterase
Patricia A. Vignaux, Eni Minerali, Thomas R. Lane, et al.
Chemical Research in Toxicology (2021) Vol. 34, Iss. 5, pp. 1296-1307
Open Access | Times Cited: 23

Showing 23 citing articles:

The Road to Personalized Medicine in Alzheimer’s Disease: The Use of Artificial Intelligence
Anuschka Silva‐Spínola, Inês Baldeiras, Joel P. Arrais, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 315-315
Open Access | Times Cited: 34

MegaSyn: Integrating Generative Molecular Design, Automated Analog Designer, and Synthetic Viability Prediction
Fabio Urbina, Christopher T. Lowden, Joseph Culberson, et al.
ACS Omega (2022) Vol. 7, Iss. 22, pp. 18699-18713
Open Access | Times Cited: 29

Validation of Acetylcholinesterase Inhibition Machine Learning Models for Multiple Species
Patricia A. Vignaux, Thomas R. Lane, Fabio Urbina, et al.
Chemical Research in Toxicology (2023) Vol. 36, Iss. 2, pp. 188-201
Open Access | Times Cited: 11

Deep Scoring Neural Network Replacing the Scoring Function Components to Improve the Performance of Structure-Based Molecular Docking
Lijuan Yang, Guanghui Yang, Xiaolong Chen, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 12, pp. 2133-2142
Closed Access | Times Cited: 16

Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents
Kushagra Kashyap, Mohammad Imran Siddiqi
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1517-1539
Closed Access | Times Cited: 14

Methoxy-naphthyl-Linked N-Benzyl Pyridinium Styryls as Dual Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Structure–Activity Relationship
Mohd Abdullaha, Razia Banoo, Vijay K. Nuthakki, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17591-17608
Open Access | Times Cited: 5

Chlorine‐Thymol Substituted Silicon (IV) Phthalocyanines: Synthesis, Characterization, and In Vitro Acetylcholinesterase (AChE)/Butyrylcholinesterase (BChE) Inhibitory Effect
Ayşe Aktaş Kamiloğlu, Tayfun Arslan, Aşkın TEKİN, et al.
Applied Organometallic Chemistry (2024) Vol. 39, Iss. 1
Closed Access | Times Cited: 1

The commoditization of AI for molecule design
Fabio Urbina, Sean Ekins
Artificial Intelligence in the Life Sciences (2022) Vol. 2, pp. 100031-100031
Open Access | Times Cited: 7

Multiple approaches to repurposing drugs for neuroblastoma
Laura Rank, Ana C. Puhl, Tammy M. Havener, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117043-117043
Open Access | Times Cited: 7

Preventing AI From Creating Biochemical Threats
Fabio Urbina, Filippa Lentzos, Cédric Invernizzi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 3, pp. 691-694
Closed Access | Times Cited: 3

Binding mechanism of perphenazine/thioridazine with acetylcholinesterase: Spectroscopic surface plasmon resonance and molecular docking based analysis
Nastaran Aletaha, Gholamreza Dehghan, Leila Sadeghi, et al.
Journal of Molecular Liquids (2023) Vol. 377, pp. 121547-121547
Closed Access | Times Cited: 2

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
Patricia A. Vignaux, Thomas R. Lane, Ana C. Puhl, et al.
ACS Omega (2023) Vol. 8, Iss. 13, pp. 12532-12537
Open Access | Times Cited: 2

In silico drug discovery: a machine learning-driven systematic review
Sema Atasever
Medicinal Chemistry Research (2024)
Closed Access

Revolutionizing Drug Discovery
Anu Sayal, Janhvi Jha, N Chaithra, et al.
(2024), pp. 189-221
Closed Access

Therapeutic effects of tilorone on mammary carcinogenesis through downregulation of pro‐inflammatory cytokines and oxidative stress
Abu Sufiyan Chhipa, Ayush Sharma, Srashti Verma, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Closed Access

Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Qi Zhang, Meng Liu, Yue Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access

Rhodium(III)-Catalyzed Sequential Cyclization of Enaminones with 1,3-Dienes via C–H Activation for the Synthesis of Fluorenones
Lei Gao, Min Wang, Hongwei Ren, et al.
The Journal of Organic Chemistry (2024)
Closed Access

MegaSyn: Integrating Generative Molecule Design, Automated Analog Designer and Synthetic Viability Prediction
Fabio Urbina, Christopher Lowden, Christopher Culberson, et al.
(2021)
Open Access | Times Cited: 4

Sensitive detection of butyrylcholinesterase activity based on a stimuli-responsive fluorescence reaction
Yuexin Pang, Zerui Ma, Qian Song, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2023) Vol. 299, pp. 122886-122886
Closed Access | Times Cited: 1

Tumours block protective muscle and nerve signals to cause cachexia
Teresa A. Zimmers
Nature (2021) Vol. 598, Iss. 7879, pp. 37-38
Closed Access | Times Cited: 1

MegaSyn: Integrating Generative Molecule Design, Automated Analog Designer and Synthetic Viability Prediction
Fabio Urbina, Christopher Lowden, Christopher Culberson, et al.
(2021)
Open Access | Times Cited: 1

Drug Repurposing Patent Applications January–March 2022
Hermann AM Mucke
Assay and Drug Development Technologies (2022) Vol. 20, Iss. 4, pp. 183-190
Closed Access

Page 1

Scroll to top